Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

Nature volume 414, pages 550–554 (2001)Cite this article

Abstract

Alteration of gene expression is a crucial component of adaptive responses to hypoxia. These responses are mediated by hypoxia-inducible transcription factors (HIFs)1,2. Here we describe an inhibitory PAS (Per/Arnt/Sim) domain protein, IPAS, which is a basic helix-loop-helix (bHLH)/PAS protein structurally related to HIFs. IPAS contains no endogenous transactivation function but demonstrates dominant negative regulation of HIF-mediated control of gene expression. Ectopic expression of IPAS in hepatoma cells selectively impairs induction of genes involved in adaptation to a hypoxic environment, notably the vascular endothelial growth factor (VEGF) gene, and results in retarded tumour growth and tumour vascular density in vivo. In mice, IPAS was predominantly expressed in Purkinje cells of the cerebellum and in corneal epithelium of the eye. Expression of IPAS in the cornea correlates with low levels of expression of the VEGF gene under hypoxic conditions. Application of an IPAS antisense oligonucleotide to the mouse cornea induced angiogenesis under normal oxygen conditions, and demonstrated hypoxia-dependent induction of VEGF gene expression in hypoxic corneal cells. These results indicate a previously unknown mechanism for negative regulation of angiogenesis and maintenance of an avascular phenotype.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IPAS is a bHLH/PAS factor.
Figure 2: In situ hybridization analysis of IPAS expression in mouse cornea, retina and cerebellum.
Figure 3: IPAS is a dominant negative regulator of HIFs.
Figure 4: Expression of IPAS in hepatoma cells retards tumour growth.
Figure 5: Evidence that IPAS functions as an inhibitor of angiogenesis in the cornea.

Similar content being viewed by others

References

  1. Bunn, H. F. & Poyton, R. O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76, 839–885 (1996).

    Article  CAS  Google Scholar 

  2. Wenger, R. H. Mammalian oxygen sensing, signalling and gene regulation. J. Exp. Biol. 203, 1253–1263 (2000).

    CAS  PubMed  Google Scholar 

  3. Krogh, A., Brown, M., Mian, I. S., Sjolander, K. & Haussler, D. Hidden Markov models in computational biology. Applications to protein modeling. J. Mol. Biol. 235, 1501–1531 (1994).

    Article  CAS  Google Scholar 

  4. Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).

    Article  ADS  CAS  Google Scholar 

  5. Ema, M. et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl Acad. Sci. USA 94, 4273–4278 (1997).

    Article  ADS  CAS  Google Scholar 

  6. Tian, H., McKnight, S. L. & Russell, D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72–82 (1997).

    Article  CAS  Google Scholar 

  7. Semenza, G. L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983–1991 (2000).

    CAS  PubMed  Google Scholar 

  8. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y. & Poellinger, L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519–6525 (1999).

    Article  CAS  Google Scholar 

  9. Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).

    Article  ADS  CAS  Google Scholar 

  10. Wiesener, M. S. et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92, 2260–2268 (1998).

    CAS  PubMed  Google Scholar 

  11. Li, H., Ko, H. P. & Whitlock, J. P. Induction of phosphoglycerate kinase 1 gene expression by hypoxia. Roles of Arnt and HIF1α. J. Biol. Chem. 271, 21262–21267 (1996).

    Article  CAS  Google Scholar 

  12. Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604–4613 (1996).

    Article  CAS  Google Scholar 

  13. Poellinger, L. in Inducible Gene Expression (ed. Baeuerle, P. A.) 177–205 (Birkhäuser, Boston, 1995).

    Book  Google Scholar 

  14. Thakur, A., Willcox, M. D. & Stapleton, F. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. J. Clin. Immunol. 18, 61–70 (1998).

    Article  CAS  Google Scholar 

  15. Sack, R. A., Beaton, A. R. & Sathe, S. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization. Curr. Eye Res. 18, 186–193 (1999).

    Article  CAS  Google Scholar 

  16. Gradin, K. et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221–5231 (1996).

    Article  CAS  Google Scholar 

  17. Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 14, 34–44 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Zundel, W. et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391–396 (2000).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Li, J. et al. PR 39, a peptide regulator of angiogenesis. Nature Med. 6, 49–55 (2000).

    Article  CAS  Google Scholar 

  20. Norton, J. D., Deed, R. W., Craggs, G. & Sablitzky, F. Id helix-loop-helix protein in cell growth and differentiation. Trends Cell Biol. 8, 58–65 (1998).

    CAS  PubMed  Google Scholar 

  21. Eddy, S. R. Multiple alignment using hidden Markov models. Ismb 3, 114–120 (1995).

    CAS  PubMed  Google Scholar 

  22. Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1α by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19, 4298–4309 (2000).

    Article  CAS  Google Scholar 

  23. Bertilsson, G. et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl Acad. Sci. USA 95, 12208–12213 (1998).

    Article  ADS  CAS  Google Scholar 

  24. Cao, R. et al. Suppression of aniogenesis by a novel inhibitor, K1-5, generated by plasmin-mediated proteolysis. Proc. Natl Acad. Sci. USA 96, 5728–5733 (1999).

    Article  ADS  CAS  Google Scholar 

Download references

Acknowledgements

We thank Y. Fujii-Kuriyama and I. Pongratz for reagents. This work was supported by grants from the Swedish Medical Research Council, Pharmacia Corporation, Swedish Cancer Society, the Human Frontiers Science Program, the Uehara Memorial Foundation, and the Japanese Ministry of Education, Culture, Sports, Science and Technology.

Author information

Author notes

  1. Mikael Asman & Anders Berkenstam

    Present address: Karobia AB, S-141 57, Huddinge, Sweden

  2. Göran Bertilsson

    Present address: Neuronova AB, S-114 33, Stockholm, Sweden

  3. Kristian Svensson

    Present address: Leica Microsystems AB, S-191 27, Solléntuna, Sweden

Authors and Affiliations

  1. Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institutet, Stockholm, S-171 77, Sweden

    Yuichi Makino & Lorenz Poellinger

  2. Department of Microbiology and Tumor Biology, Karolinska Institutet, Stockholm, S-171 77, Sweden

    Renhai Cao & Yihai Cao

  3. Center for Genomics and Bioinformatics, Karolinska Institutet, Stockholm, S-171 77, Sweden

    Mikael Asman

  4. Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, 108-8639, Tokyo, Japan

    Yuichi Makino & Hirotoshi Tanaka

  5. Pharmacia Corporation, Stockholm, S-112 87, Sweden

    Kristian Svensson, Göran Bertilsson & Anders Berkenstam

  6. Karobia AB, S-141 57, Huddinge, Sweden

    Kristian Svensson & Göran Bertilsson

  7. Neuronova AB, S-114 33, Stockholm, Sweden

    Kristian Svensson & Anders Berkenstam

  8. Leica Microsystems AB, S-191 27, Solléntuna, Sweden

    Göran Bertilsson & Anders Berkenstam

Authors
  1. Yuichi Makino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renhai Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kristian Svensson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Göran Bertilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mikael Asman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hirotoshi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yihai Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Anders Berkenstam
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lorenz Poellinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorenz Poellinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makino, Y., Cao, R., Svensson, K. et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550–554 (2001). https://doi.org/10.1038/35107085

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35107085

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing